Syra Health Corp. Class A Common Stock (SYRA) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Syra Health Corp. Class A Common Stock (SYRA) trades at $0.8542 with AI Score 45/100 (Grade C). Syra Health Corp. Market cap: $10.2M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for SYRA: SYRA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SYRA against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SYRA: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Syra Health Corp. Class A Common Stock (SYRA) Healthcare & Pipeline Overview
Syra Health Corp. delivers health education, population health management, and digital health solutions, targeting mental health facilities and government agencies. With a focus on telehealth and digital transformation, Syra operates in the evolving healthcare services sector, marked by a negative profit margin and high beta.
What Is the Investment Thesis for SYRA?
Syra Health Corp. operates in the growing healthcare services market, with a focus on digital health and telehealth solutions. The company's diverse service offerings, including health education, population health management, and mental health services, position it to capitalize on the increasing demand for integrated healthcare solutions. Key value drivers include the expansion of its Syrenity telehealth platform and the growth of its digital health solutions. However, the company's negative profit margin of -12.4% and high beta of 3.96 indicate significant financial risk. The company's small market capitalization also presents liquidity concerns. Investors should carefully weigh the growth potential against the financial risks before considering an investment in Syra Health.
Based on FMP financials and quantitative analysis
SYRA Key Highlights
Syra Health Corp. operates with a market capitalization of $10.2M, indicating its status as a micro-cap company.
- The company's P/E ratio is -1.40, reflecting its current lack of profitability.
- Syra Health Corp. has a negative profit margin of -12.4%, highlighting challenges in achieving profitability.
- The company's gross margin is 29.8%, suggesting potential for improved profitability with efficient cost management.
- Syra Health Corp. has a high beta of 3.96, indicating significant volatility compared to the broader market.
Who Are SYRA's Competitors?
SYRA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CCM Concord Medical Services Holdings Limited | $5.09 | +6.04% | — | |
| PETV PetVivo Holdings, Inc. | $0.67 | -1.18% | $25.2M | 58 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SYRA's Key Strengths?
Diverse service offerings including health education, population health management, and digital health.
- Focus on telehealth and digital health solutions.
- Strong relationships with mental health hospitals and government agencies.
- Development of proprietary Syrenity telehealth platform.
What Are SYRA's Weaknesses?
Negative profit margin indicating financial challenges.
- Small market capitalization and limited financial resources.
- High beta indicating significant volatility.
- Limited brand recognition compared to larger competitors.
What Could Drive SYRA Stock Higher?
Expansion of Syrenity telehealth platform to increase market reach and service offerings.
- Growth in digital health solutions to capitalize on the increasing adoption of digital healthcare technologies.
- Strategic partnerships with healthcare organizations to expand service delivery and customer base.
- Development and launch of new health education programs to improve patient outcomes and engagement.
- Expansion of healthcare staffing solutions to address the growing shortage of healthcare professionals.
What Are the Key Risks for SYRA?
Intense competition from larger, more established players in the healthcare services industry.
- Regulatory changes and healthcare reform that could impact the company's business model.
- Economic downturn that could reduce demand for healthcare services.
- Cybersecurity threats and data breaches that could compromise patient data and damage the company's reputation.
- Negative profit margin indicating financial challenges and potential liquidity issues.
What Are the Growth Opportunities for SYRA?
- Growth opportunity 1: Expansion of Syrenity Telehealth Platform: Syra Health's development of Syrenity, an on-demand telehealth platform for mental health services, presents a significant growth opportunity. The telehealth market is projected to reach $55.6 billion by 2027, driven by increasing demand for remote healthcare services. By expanding the features and reach of Syrenity, Syra Health can capture a larger share of this growing market and improve access to mental health services. Timeline: Ongoing.
- Growth opportunity 2: Digital Health Solutions: Syra Health's digital health solutions, including digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps, offer substantial growth potential. By developing innovative digital health solutions tailored to the needs of its clients, Syra Health can drive revenue growth and enhance its competitive position. Timeline: Ongoing.
- Growth opportunity 3: Healthcare Workforce Solutions: Syra Health's healthcare staffing solutions address the growing demand for qualified healthcare professionals. The healthcare staffing market is projected to reach $44.7 billion by 2027, driven by shortages of nurses, physicians, and other healthcare workers. By providing flexible and cost-effective staffing solutions, Syra Health can help healthcare organizations meet their workforce needs and improve patient care. Timeline: Ongoing.
- Growth opportunity 4: Population Health Management Services: Syra Health's population health management services, including analytics as a service, epidemiology, and health equity analytics solutions, offer a valuable service to healthcare organizations seeking to improve patient outcomes and reduce costs. The population health management market is expected to reach $69.2 billion by 2027, driven by the increasing focus on value-based care and preventative medicine. By providing data-driven insights and solutions, Syra Health can help healthcare organizations optimize their population health management strategies. Timeline: Ongoing.
- Growth opportunity 5: Health Education Services: Syra Health's health education services, including medical communications, patient education, and healthcare training, address the critical need for effective communication and education in healthcare. The health education market is expected to grow as healthcare organizations increasingly recognize the importance of patient engagement and adherence. By providing engaging and informative health education programs, Syra Health can help improve patient outcomes and satisfaction. Timeline: Ongoing.
What Are SYRA's Competitive Advantages?
- Diverse service offerings provide a comprehensive suite of healthcare solutions.
- Focus on digital health and telehealth solutions positions the company for future growth.
- Strong relationships with mental health hospitals and government agencies.
- Proprietary Syrenity telehealth platform offers a competitive advantage.
What Does SYRA Do?
Syra Health Corp., established in 2020 and headquartered in Carmel, Indiana, is a healthcare services company that provides a suite of solutions, including health education, population health management, behavioral and mental health services, healthcare workforce solutions, and digital health services. The company's health education services encompass medical communications, patient education, and healthcare training programs. Its population health management services include analytics as a service, epidemiology, and health equity analytics solutions, designed to improve patient outcomes and reduce healthcare costs. Syra Health is also developing Syrenity, a telehealth platform focused on delivering mental health services on-demand. Furthermore, the company offers healthcare staffing solutions and digital health solutions, including digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. Syra Health serves a diverse clientele, including mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers, positioning itself as a versatile partner in the healthcare ecosystem.
What Products and Services Does SYRA Offer?
- Provides health education services, including medical communications and patient education.
- Offers population health management services, such as analytics and epidemiology solutions.
- Develops Syrenity, an on-demand telehealth platform for mental health services.
- Provides healthcare staffing solutions to hospitals and healthcare organizations.
- Offers digital health solutions, including digital transformation and cloud security.
- Serves mental health hospitals, government agencies, and managed care entities.
How Does SYRA Make Money?
- Generates revenue through health education services provided to healthcare organizations.
- Earns revenue from population health management services, including data analytics and consulting.
- Monetizes its Syrenity telehealth platform through subscription fees and service charges.
- Derives income from healthcare staffing solutions provided to hospitals and clinics.
What Industry Does SYRA Operate In?
Syra Health Corp. operates within the healthcare services industry, which is experiencing significant growth due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology. The industry is characterized by intense competition, with companies vying for market share in areas such as telehealth, digital health, and population health management. Syra Health's focus on integrated healthcare solutions and its diverse service offerings position it to compete effectively in this dynamic landscape. However, the company faces challenges from larger, more established players with greater resources and brand recognition.
Who Are SYRA's Key Customers?
- Mental health hospitals and organizations seeking comprehensive healthcare solutions.
- Government agencies requiring population health management and health education services.
- Integrated health networks looking for digital health and telehealth solutions.
- Managed care entities seeking to improve patient outcomes and reduce healthcare costs.
- Pharmaceutical manufacturers requiring medical communications and patient education programs.
Key Financial Metrics
Return on equity for Syra Health Corp. Class A Common Stock stands at 5.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.4%, showing how much profit it generates from its asset base. SYRA trades at a trailing price-to-earnings ratio of 91.31, above the Healthcare sector average of ~23x. Its free cash flow yield is 0.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.13 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.1%, the inverse of the P/E and a quick read on earnings relative to price.
Syra Health Corp. Class A Common Stock (SYRA) Valuation Context
Valued at $10.2M, SYRA is classified as a micro-cap stock. Relative to its peer group, SYRA's quantitative score of 45/100 is below the peer average of 56/100.
Company Profile
Syra Health Corp. Class A Common Stock operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Carmel, US. The company is led by CEO Gregory R. Alexander. SYRA has traded publicly since 2023.
Financial Health
Syra Health Corp. Class A Common Stock's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.33 places it in the safe zone, indicating low near-term bankruptcy risk.
SYRA Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in future performance, indicating that key stakeholders believe in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting Syra's innovative approach to healthcare solutions and their impact on patient outcomes.
- Market perception has improved due to recent partnerships that enhance Syra's service offerings, attracting more attention from investors and consumers alike.
- Increased media coverage has spotlighted Syra's advancements, generating buzz and interest that could lead to higher market engagement.
Bear Case
- Some analysts have raised concerns about the scalability of Syra's business model, questioning whether current growth can be sustained long-term.
- Negative community sentiment persists around potential regulatory challenges that could impact Syra's operations and market entry strategies.
- Recent earnings reports have shown mixed results, leading to skepticism among investors about the company's ability to meet future expectations.
- There are ongoing discussions about competition in the healthcare space, with some believing that Syra may struggle to differentiate itself in a crowded market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SYRA Latest News
No recent news available for SYRA.
SYRA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SYRA.
Price Targets
Wall Street price target analysis for SYRA.
SYRA MoonshotScore
What does this score mean?
The MoonshotScore rates SYRA 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest Syra Health Corp. Class A Common Stock Analysis
Leadership: Gregory R. Alexander
Unknown
Information about Gregory R. Alexander's background is not available in the provided context. Therefore, his career history, education, and previous roles are unknown. Further research would be needed to provide a comprehensive biography.
Track Record: Information about Gregory R. Alexander's track record is not available in the provided context. Key achievements, strategic decisions, and company milestones under his leadership are unknown. Further research would be needed to evaluate his performance as CEO.
SYRA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Syra Health Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in Syra Health Corp.
- Lower trading volumes and wider bid-ask spreads can lead to price volatility and illiquidity.
- Lack of regulatory oversight on the OTC Other tier increases the potential for fraud and manipulation.
- Limited access to capital markets can hinder the company's ability to raise funds for growth and expansion.
- The OTC Other tier may attract speculative trading, increasing the risk of sudden price swings.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth prospects and potential risks.
- Consult with a financial advisor before investing.
- Check for any legal or regulatory issues involving the company.
- Understand the risks associated with investing in OTC stocks.
- Company incorporation in 2020 suggests a relatively new business.
- Headquarters located in Carmel, Indiana.
- Provides a range of healthcare services, including health education and digital health solutions.
- Serves mental health hospitals and government agencies.
What Investors Ask About Syra Health Corp. Class A Common Stock (SYRA) — Healthcare
What does the AI Score mean for SYRA?
SYRA holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Syra Health Corp. provides a range of healthcare services, including health education, population health management, and digital health solutions. The company focuses on serving mental health …
What does Syra Health Corp. Class A Common Stock do?
Syra Health Corp. operates as a healthcare services company, providing a range of solutions including health education, population health management, behavioral and mental health services, healthcare workforce solutions, and digital health services. The company develops and offers medical communications, patient education, and healthcare training programs. Syra Health also provides analytics, epidemiology, and health equity analytics solutions.
What are the main risks for SYRA?
Syra Health Corp. faces several risks, including intense competition from larger, more established players in the healthcare services industry. The company's negative profit margin and small market capitalization pose financial risks. Regulatory changes and healthcare reform could also impact the company's business model. Additionally, cybersecurity threats and data breaches could compromise patient data and damage the company's reputation. The OTC listing and limited financial disclosure add further risks for investors.
What are the key factors to evaluate for SYRA?
Syra Health Corp. Class A Common Stock (SYRA) holds an AI score of 45/100 (low). operates in the growing healthcare services market, with a focus on digital health and telehealth solutions. Not financial advice.
How frequently does SYRA data refresh on this page?
SYRA's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SYRA's recent stock price performance?
Syra Health Corp. Class A Common Stock (SYRA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse service offerings including health education, population health management, and digital health. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SYRA overvalued or undervalued right now?
Syra Health Corp. Class A Common Stock (SYRA) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SYRA before investing?
Before investing in Syra Health Corp. Class A Common Stock (SYRA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SYRA to a portfolio?
Key strength of Syra Health Corp. Class A Common Stock (SYRA): Diverse service offerings including health education, population health management, and digital health. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of March 16, 2026.
- OTC market data may be limited or delayed.
- AI analysis is pending and may provide further insights.